Acute hepatitis associated with levofloxacin in a patient with renal insufficiency
Abstract
Jon-David Schwalm and Christine Lee[1][1] reported a case of acute hepatitis in a hemodialysis patient taking oral levofloxacin. We observed profuse epistaxis and an acute rise in hepatic enzyme levels, particularly alkaline phosphatase, with levofloxacin therapy in a 63-year-old patient with mitral
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.